Skip to main content

Table 1 Patient characteristics

From: The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

Patients (n) 101
Age median (range) 69 years (43–87)
PSA median (range) 11.113 ng/ml (0.970–178.200)
IR(n) 49
HR(n) 52
GS  
 GS 6 4
 GS 7a 30
 GS 7b 37
 GS 8 9
 GS 9 21
Clinical T-stage  
 T1c 41
 T2a 9
 T2b 7
 T2c 39
 T3a 2
 T3b 3
  1. N, number; IR, intermediate-risk group; HR, high-risk group; GS, Gleason score; GS 7a corresponds to GS 3 + 4; GS 7b corresponds to GS 4 + 3